Splenic tissue alterations in ST-elevation myocardial infarction: determinants and prognostic implications

Ting-Xuan Yin1, Guo-Jun Zhu1, Xing-Yu Gu1

  • 1Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, No. 160 PuJian Rd, Pudong New Area, Shanghai 200127, China.

Insights

Cardiac magnetic resonance (CMR) can detect splenic T1 alterations after ST-segment-elevation myocardial infarction (STEMI). Elevated splenic T1 z-score and extracellular volume (ECV) predict major adverse cardiovascular events (MACE), offering improved risk prediction.

Area of Science:

  • Cardiology
  • Radiology
  • Biomedical Imaging

Background:

  • The cardio-splenic axis suggests splenic involvement in systemic inflammation post-myocardial infarction.
  • Clinical significance of splenic tissue changes on cardiac magnetic resonance (CMR) in ST-segment-elevation myocardial infarction (STEMI) is not well-defined.

Purpose of the Study:

  • To identify determinants of splenic T1 patterns in STEMI patients using CMR.
  • To investigate the association between splenic T1 patterns and adverse cardiovascular outcomes.

Main Methods:

  • Retrospective analysis of STEMI patients undergoing CMR within 10 days of primary percutaneous coronary intervention.
  • Evaluation of splenic T1 times and extracellular volume (ECV) using CMR.
  • Follow-up for major adverse cardiovascular events (MACE) including cardiovascular death, heart failure, and re-infarction.

Main Results:

  • Elevated splenic T1 z-score and splenic ECV independently predicted MACE in multivariable Cox regression.
  • These splenic alterations were primarily associated with increased risk of heart failure and non-target vessel re-infarction.
  • A model incorporating splenic T1 z-score with clinical and myocardial imaging factors showed superior discrimination for MACE prediction.

Conclusions:

  • Splenic T1 z-score and ECV measured by CMR after STEMI are independent predictors of MACE.
  • These findings provide incremental prognostic value beyond traditional risk markers.
  • Splenic imaging may enhance risk stratification in STEMI patients.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
630
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
485
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
762
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.9K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
490